ClinConnect ClinConnect Logo
Search / Trial NCT06988735

Impact of Total Coronary Revascularization Via Left Anterior Thoracotomy (TCRAT) vs. Robotic-Assisted Harvesting of LIMA (ITcrats)

Launched by MOHAMED R EL TAHAN · May 16, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Minimally Invasive Coronary Revascularization Surgery Robotic Assisted Coronary Artery Bypass Graft (Ra Cabg) Major Adverse Cardiovascular Events (Macce) Major Adverse Cerebrovascular Events Cardiopulmonary Bypass (Cpb) Hospital Stays Costs And Charges

ClinConnect Summary

This clinical trial is studying two different ways to perform a heart surgery called total coronary revascularization. The goal is to see if one method, which uses robotic assistance, is better than the other method that does not use robots. Researchers want to find out which method leads to shorter hospital stays, lower healthcare costs, and is safer for patients. If both methods are found to be equally effective and safe, the non-robotic method may be preferred because it is easier to perform.

To be eligible for this trial, participants should be scheduled for elective heart surgery that requires the use of a heart-lung machine and will be under general anesthesia. However, certain patients cannot participate, such as those who are pregnant, require emergency surgery, or have specific health issues like severe heart failure. If you join the trial, you can expect close monitoring during your surgery and recovery, and you’ll be contributing to important research that could help improve heart surgery techniques in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Scheduled for any type of elective minimally invasive coronary revascularization surgery.
  • Using CPB.
  • General anesthesia is provided in an endotracheally intubated patient
  • Exclusion Criteria:
  • Planned for coronary revascularization surgery without CPB;
  • Planned for a combined coronary revascularization surgery and a valve or intra-cardiac surgery;
  • LVEF less than 35%;
  • Preoperative cardiogenic shock;
  • Pregnancy;
  • Scheduled for re-do or emergency surgery;
  • Consent for another interventional study during anesthesia;
  • No written informed consent;
  • Preoperative need for mechanical circulatory support;
  • Preoperative need for invasive ventilatory support;

About Mohamed R El Tahan

Mohamed R. El Tahan is a distinguished clinical trial sponsor with a focus on advancing medical research and innovation. With a commitment to improving patient outcomes, he leads initiatives that prioritize rigorous scientific methodologies and ethical standards in clinical trials. His expertise spans various therapeutic areas, fostering collaborations with healthcare professionals and institutions to ensure comprehensive study designs and robust data analysis. Under his guidance, clinical trials are conducted with a strong emphasis on patient safety and regulatory compliance, contributing to the development of effective therapies and enhancing the overall landscape of healthcare.

Locations

Dammam, Eastern, Saudi Arabia,, Saudi Arabia

Dammam, , Saudi Arabia

Patients applied

0 patients applied

Trial Officials

Mohamed R El Tahan, MD

Study Chair

Consultant in Cardiac Anesthesia

Fahad Makhdoum, MD

Principal Investigator

Assistant Professor, Cardiac Surgery

Yasser F ElGhoneimy, MD

Study Director

Professor, Cardiac Surgery

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported